AC Immune SA
Hedge Funds Holdings
Last updated:
AC Immune SA‘s stocks are currently a part of 35 hedge funds’ portfolios, which represents 19.07% of the total amount of its stocks outstanding. This makes up a total of 14.29M shares of AC Immune SA. Compared to the previous quarter, the number fell by -5.02% or -755.70K shares fewer. As for the holding position changes, 28.57% (10) of current hedge fund investors increased the number of shares held, 34.29% (12) of current holders sold a part of the shares held, and 28.57% (10) closed the holdings completely. 3 hedge funds are new holders of AC Immune SA stock in Q1 2022, it is 8.57% of total holders.
Hedge funds holding AC Immune SA (Q2 2017 – Q1 2022)
| Q2 2017 | 17 |
|---|---|
| Q3 2017 | 15 |
| Q4 2017 | 22 |
| Q1 2018 | 18 |
| Q2 2018 | 15 |
| Q3 2018 | 32 |
| Q4 2018 | 38 |
| Q1 2019 | 39 |
| Q2 2019 | 40 |
| Q3 2019 | 36 |
| Q4 2019 | 48 |
| Q1 2020 | 47 |
| Q2 2020 | 41 |
| Q3 2020 | 50 |
| Q4 2020 | 46 |
| Q1 2021 | 50 |
| Q2 2021 | 56 |
| Q3 2021 | 62 |
| Q4 2021 | 43 |
| Q1 2022 | 35 |
Hedge funds changes in AC Immune SA positions (Q2 2017 – Q1 2022)
| Q2 2017 | 6 | 3 | 3 | 8 | -3 |
|---|---|---|---|---|---|
| Q3 2017 | 4 | 2 | 3 | 6 | 0 |
| Q4 2017 | 7 | 4 | 2 | 0 | 9 |
| Q1 2018 | 1 | 8 | 3 | 5 | 1 |
| Q2 2018 | 2 | 1 | 4 | 5 | 3 |
| Q3 2018 | 18 | 10 | 3 | 1 | 0 |
| Q4 2018 | 14 | 7 | 10 | 8 | -1 |
| Q1 2019 | 16 | 14 | 5 | 15 | -11 |
| Q2 2019 | 10 | 10 | 13 | 9 | -2 |
| Q3 2019 | 3 | 11 | 13 | 7 | 2 |
| Q4 2019 | 17 | 11 | 15 | 5 | 0 |
| Q1 2020 | 12 | 9 | 19 | 12 | -5 |
| Q2 2020 | 6 | 15 | 10 | 12 | -2 |
| Q3 2020 | 14 | 16 | 12 | 5 | 3 |
| Q4 2020 | 5 | 12 | 15 | 8 | 6 |
| Q1 2021 | 13 | 11 | 17 | 9 | 0 |
| Q2 2021 | 17 | 15 | 17 | 11 | -4 |
| Q3 2021 | 14 | 21 | 17 | 8 | 2 |
| Q4 2021 | 5 | 10 | 19 | 24 | -15 |
| Q1 2022 | 3 | 10 | 12 | 10 | 0 |
Hedge funds changes in AC Immune SA stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 2,190,000 | 792,000 |
| Q4 2020 | 1,120,000 | 671,000 |
| Q1 2021 | 2,038,000 | 2,191,000 |
| Q2 2021 | 2,139,000 | 1,363,000 |
| Q3 2021 | 1,824,000 | 976,000 |
| Q4 2021 | 593,000 | 437,000 |
| Q1 2022 | 942,000 | 439,000 |